Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologists want safer cath labs | 2 recalls to keep an eye on | New PCI data | AI tech impresses
Tuesday, August 11, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Interventional Cardiology

The fight for safer cath labs continues: ‘We have to fix the work environment’

A group of nine U.S. medical societies wants to help hospital leaders improve cath lab safety. Their primary goals are to reduce radiation exposure and prevent orthopedic injuries. 

READ MORE >
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
Share on Twitter Share on Facebook Share on Linkedin

The fight for safer cath labs continues: ‘We have to fix the work environment’

Share on Twitter Share on Facebook Share on Linkedin
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
A group of nine U.S. medical societies wants to help hospital leaders improve cath lab safety. Their primary goals are to reduce radiation exposure and prevent orthopedic injuries. 
READ MORE >

FDA shares warning about stroke prevention device after injury

Customers should return these devices to the manufacturer due to a risk of the tip separating during use. 

READ MORE >
doctor wrong patient wrong-site surgery medical error malpractice mistake
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about stroke prevention device after injury

Share on Twitter Share on Facebook Share on Linkedin
doctor wrong patient wrong-site surgery medical error malpractice mistake
Customers should return these devices to the manufacturer due to a risk of the tip separating during use. 
READ MORE >

Medtech company wants to help hospitals open radiation-free interventional MR labs

Minneapolis-based Imricor Medical Systems is asking hospital leaders to rethink the way they do business. 

READ MORE >
Imricor Cardiovascular.
Share on Twitter Share on Facebook Share on Linkedin

Medtech company wants to help hospitals open radiation-free interventional MR labs

Share on Twitter Share on Facebook Share on Linkedin
Imricor Cardiovascular.
Minneapolis-based Imricor Medical Systems is asking hospital leaders to rethink the way they do business. 
READ MORE >

Stereotaxis completes major cardiology tech acquisition

The deal, first announced in April, includes an upfront payment of $20 million and up to an additional $25 million based on certain milestones.

READ MORE >
Handshake
Share on Twitter Share on Facebook Share on Linkedin

Stereotaxis completes major cardiology tech acquisition

Share on Twitter Share on Facebook Share on Linkedin
Handshake
The deal, first announced in April, includes an upfront payment of $20 million and up to an additional $25 million based on certain milestones.
READ MORE >

Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI

After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.
READ MORE >

Blood clot removal device recalled over safety risk

Healthcare providers should return any unused devices to the manufacturer. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Blood clot removal device recalled over safety risk

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Healthcare providers should return any unused devices to the manufacturer. 
READ MORE >

Abbott gathering real-world data on FDA-approved TriClip system

Abbott's TriClip system for tricuspid regurgitation is approved by the FDA and covered by Medicare. To learn more about its real-world performance, researchers will now track 1,000 patients for a total of five years. 

READ MORE >
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
Share on Twitter Share on Facebook Share on Linkedin

Abbott gathering real-world data on FDA-approved TriClip system

Share on Twitter Share on Facebook Share on Linkedin
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
Abbott's TriClip system for tricuspid regurgitation is approved by the FDA and covered by Medicare. To learn more about its real-world performance, researchers will now track 1,000 patients for a total of five years. 
READ MORE >

New AI-powered FFR tech shows potential

The AI software, which has already received CE mark approval, provides care teams with a noninvasive way to secure FFR values from routine coronary angiography. 

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

New AI-powered FFR tech shows potential

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
The AI software, which has already received CE mark approval, provides care teams with a noninvasive way to secure FFR values from routine coronary angiography. 
READ MORE >

Topaz vs. Evoque: New head-to-head study for TTVR devices now underway

Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 

READ MORE >
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Topaz vs. Evoque: New head-to-head study for TTVR devices now underway

Share on Twitter Share on Facebook Share on Linkedin
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 
READ MORE >

In Case You Missed It

Chest pain drug lowers risk of kidney injury after PCI

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Chest pain drug lowers risk of kidney injury after PCI

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup